Maintenance durvalumab after first-line chemotherapy in patients with HER2-negative advanced oesophago-gastric adenocarcinoma: results from the randomised PLATFORM study

Authors: Fong, C., Patel, B., Peckitt, C., Bourmpaki, E., Satchwell, L., Cromarty, S., Kidd, S., von Loga, K., Uhlik, M., Begum, R., Rana, T., Waddell, T., Darby, S., Bradshaw, A., Roques, T., Morgan, C., Rees, C., Herbertson, R., Das, P., Thompson, C., Hewish, M., Petty, R., Thistlethwaite, F., Rao, S., Starling, N., Chau, I., Cunningham, D.

Source: In ESMO Open July 2024 9(7)

Investigating the feasibility of tumour molecular profiling in gastrointestinal malignancies in routine clinical practice

Authors: Moorcraft, S.Y., Gonzalez de Castro, D., Cunningham, D., Jones, T., Walker, B.A., Peckitt, C., Yuan, L.C., Frampton, M., Begum, R., Eltahir, Z., Wotherspoon, A., Teixeira Mendes, L.S., Hulkki Wilson, S., Gillbanks, A., Baratelli, C., Fotiadis, N., Patel, A., Braconi, C., Valeri, N., Gerlinger, M., Rao, S., Watkins, D., Chau, I., Starling, N. ^*

Source: In Annals of Oncology January 2018 29(1):230-236

PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer

Authors: Sclafani, F., Brown, G., Cunningham, D. ^*, Wotherspoon, A., Tait, D., Peckitt, C., Evans, J., Yu, S., Sena Teixeira Mendes, L., Tabernero, J., Glimelius, B., Cervantes, A., Thomas, J., Begum, R., Oates, J., Chau, I.

Source: In Annals of Oncology August 2016 27(8):1557-1565

Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial

Authors: Sclafani, F., Chau, I., Cunningham, D., Peckitt, C., Lampis, A., Hahne, J.C., Braconi, C., Tabernero, J., Glimelius, B., Cervantes, A., Begum, R., Gonzalez De Castro, D., Hulkki Wilson, S., Eltahir, Z., Wotherspoon, A., Tait, D., Brown, G., Oates, J., Valeri, N. ^*

Source: In Annals of Oncology September 2015 26(9):1936-1941

P1187: END OF TREATMENT 18F FDG-PET/CT RESPONSE IS PROGNOSTIC FOR OVERALL AND PROGRESSION-FREE SURVIVAL IN PERIPHERAL T-CELL LYMPHOMA: RESULTS OF THE UK NCRI PHASE 2 RANDOMISED CHEMO-T TRIAL PET/CT SUBSTUDY

Authors: Gleeson, M., Arias, C., Cunningham, D., Peckitt, C., Du, Y., Hujairi, N., To, Y. M., Chen, H.-C., Patel, S., Chau, I., Johnson, P., Ardeshna, K. M., Wotherspoon, A., Attygalle, A., Hawkes, E. A., Macheta, M. P., Collins, G. P., Radford, J., Forbes, A., Hart, A., Montoto, S., McKay, P., Benstead, K., Morley, N., Kalakonda, N., Hasan, Y., Turner, D., Chua, S.

Source: HemaSphere. 6:1073-1074

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165715952.0x000001&indx=1&recIds=ETOCvdc_100165715952.0x000001

RAS mutations and cetuximab in locally advanced rectal cancer: Results of the EXPERT-C trial

Authors: Sclafani, F., Gonzalez, D., Cunningham, D., Hulkki Wilson, S., Peckitt, C., Giralt, J., Glimelius, B., Roselló Keränen, S., Wotherspoon, A., Brown, G., Tait, D., Oates, J., Chau, I.

Source: In European Journal of Cancer May 2014 50(8):1430-1436

A study of motivations and expectations of patients seen in phase 1 oncology clinics

Authors: Dolly, S. O., Kalaitzaki, E., Puglisi, M., Stimpson, S., Hanwell, J., Fandos, S. S., Stapleton, S., Ansari, T., Peckitt, C., Kaye, S.

Source: CANCER -PHILADELPHIA THEN HOBOKEN-. 122(22):3501-3508

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN382721687&indx=1&recIds=ETOCRN382721687

Improved survival in resected oesophageal and gastric adenocarcinomas over a decade: the Royal Marsden experience 2001–2010

Authors: Fontana, E., Smyth, E. C., Cunningham, D., Rao, S., Watkins, D., Allum, W. H., Thompson, J., Waddell, T., Peckitt, C., Chau, I.

Source: GASTRIC CANCER. 19(4):1114-1124

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN379358315&indx=1&recIds=ETOCRN379358315

Exclusion of Gastrointestinal Cancer Patients With Prior Cancer From Clinical Trials: Is This Justified?

Authors: Smyth, E. C., Tarazona, N., Peckitt, C., Armstrong, E., Mansukhani, S., Cunningham, D., Chau, I.

Source: CLINICAL COLORECTAL CANCER. 15(2):e53-e59

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN378532473&indx=1&recIds=ETOCRN378532473

Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial

Authors: Grenader, T., Waddell, T., Peckitt, C., Oates, J., Starling, N., Cunningham, D., Bridgewater, J.

Source: ANNALS OF ONCOLOGY. 27(4):687-692

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN376971971&indx=1&recIds=ETOCRN376971971

HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab

Authors: Sclafani, F., Roy, A., Cunningham, D. ^*, Wotherspoon, A., Peckitt, C., Gonzalez de Castro, D., Tabernero, J., Glimelius, B., Cervantes, A., Eltahir, Z., Oates, J., Chau, I.

Source: In Annals of Oncology December 2013 24(12):3123-3128

Rituximab, Gemcitabine, Cisplatin and Methylprednisolone (R-GEM-P) is an effective regimen in relapsed diffuse large B-cell lymphoma

Authors: Barton, S., Hawkes, E. A., Cunningham, D., Peckitt, C., Chua, S., Wotherspoon, A., Attygalle, A., Horwich, A., Potter, M., Ethell, M.

Source: EUROPEAN JOURNAL OF HAEMATOLOGY. 94(3):219-226

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN367875250&indx=1&recIds=ETOCRN367875250

1424P Maintenance capecitabine plus ramucirumab after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma (OGA): Final analysis from the PLATFORM trial

Authors: Gordon, A., Rajan, Z., Fong, C.Y.K., Peckitt, C., Satchwell, L., Cromarty, S., Kidd, S., Piadel, K., Leamon, B., Zhitkov, O., Davidson, M., Thompson, J., Maisey, N.R., Darby, S., Waddell, T.S., Morgan, C., Bradshaw, A., Starling, N., Chau, I., Cunningham, D.

Source: In Annals of Oncology September 2024 35 Supplement 2:S888-S888

Delivery characteristics and patients’ handling of two single-dose dry-powder inhalers used in COPD

Authors: Chapman KR, Fogarty CM, Peckitt C, Lassen C, Jadayel D, Dederichs J, Dalvi M, Kramer B

Source: International Journal of COPD, Vol 2011, Iss default, Pp 353-363 (2011)

Subject Terms: Diseases of the respiratory system, RC705-779

File Description: electronic resource

Relation: http://www.dovepress.com/delivery-characteristics-and-patientsrsquo-handling-of-two-single-dose-a7721; https://doaj.org/toc/1176-9106; https://doaj.org/toc/1178-2005

Access URL: https://doaj.org/article/381250ae8eee4906ab6c1f919c9c420b

FOLFIRINOX for Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: The Royal Marsden Experience

Authors: Moorcraft, S. Y., Khan, K., Peckitt, C., Watkins, D., Rao, S., Cunningham, D., Chau, I.

Source: CLINICAL COLORECTAL CANCER. 13(4):232-238

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN362518970&indx=1&recIds=ETOCRN362518970

GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma

Authors: Hawkes, E. A., Barton, S., Cunningham, D., Peckitt, C., Chua, S., Wotherspoon, A., Horwich, A., Potter, M., Ethel, M., Dearden, C.

Source: ANNALS OF HEMATOLOGY. 93(5):827-834

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN350761596&indx=1&recIds=ETOCRN350761596

Patupilone in patients with pretreated metastatic/locally recurrent colorectal cancer: results of the Phase II CINATRA trial

Authors: Moorcraft, S. Y., Chau, I., Peckitt, C., Cunningham, D., Rao, S., Yim, K. L., Walther, A., Jackson, C. G., Stamp, G., Webb, J.

Source: INVESTIGATIONAL NEW DRUGS. 31(5):1339-1344

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN338880545&indx=1&recIds=ETOCRN338880545

Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison

Authors: Mahler, D.A., D Urzo, A., Bateman, E.D., Ozkan, S.A., White, T., Peckitt, C., Lassen, C., Kramer, B., INTRUST-1 and INTRUST-2 study investigators

Source: THORAX -LONDON-. 67(9):781-788

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN318108491&indx=1&recIds=ETOCRN318108491

Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients

Authors: Siergiejko, Z., SŚwiebocka, E., Smith, N., Peckitt, C., Leo, J., Peachey, G., Maykut, R.

Source: CURRENT MEDICAL RESEARCH AND OPINION. 27(11):2223-2228

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN300324690&indx=1&recIds=ETOCRN300324690

Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma

Authors: Bousquet, J., Siergiejko, Z., wiebocka, E., Humbert, M., Rabe, K. F., Smith, N., Leo, J., Peckitt, C., Maykut, R., Peachey, G.

Source: ALLERGY -COPENHAGEN-. 66(5):671-678

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN293050520&indx=1&recIds=ETOCRN293050520